FDMT vs JCI · rev $6.8M vs P/E 44, rev $23.60B
4D Molecular Therapeutics Inc (FDMT) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported FDMT revenue for 2026-06-30 was $6.8M. Net income was -$141.7M. FDMT currently screens at market cap $518.1M.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
FDMT currently screens at market cap $518.1M. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the FDMT and JCI stock pages for the full models.
Not investment advice.